Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Main Authors: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2006
|
Lignende værker
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
af: Mukhtyar, C, et al.
Udgivet: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
af: Mukhtyar, C, et al.
Udgivet: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
af: Saket Jha, et al.
Udgivet: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
af: Zhi-Ying Li, et al.
Udgivet: (2020-08-01) -
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
af: Moog P, et al.
Udgivet: (2015-11-01)